Frontiers | Gastrointestinal and Hepatic Involvement in Cystic Fibrosis in the era of CFTR Modulator Therapies

Gastrointestinal and Hepatic Involvement in Cystic Fibrosis in the era of CFTR Modulator Therapies

1,076
Total downloads
4,624
Total views and downloads

Articles

CASE REPORT

Published on 23 Oct 2024

Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis

Michael P. Coughlin
Senthilkumar Sankararaman
Erica A. Roesch
Emily D. Certo
Benjamin L. Brej
Michael W. Konstan

Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis

doi 10.3389/fped.2024.1457517

563 views
1 citation

MINI REVIEW

Published on 07 Aug 2024

Metabolic alkalosis in cystic fibrosis: from vascular volume depletion to impaired bicarbonate excretion

Manoocher Soleimani

Metabolic alkalosis in cystic fibrosis: from vascular volume depletion to impaired bicarbonate excretion

doi 10.3389/fendo.2024.1411317

1,338 views

ORIGINAL RESEARCH

Published on 11 Apr 2024

Pancreatic enzymes digest obstructive meconium from cystic fibrosis pig intestines

Gopinathan Gangadharan Nambiar
Sussette Gonzalez Szachowicz
Christian F. Zirbes
Jared J. Hill
Linda S. Powers
David K. Meyerholz
Ian M. Thornell
David A. Stoltz
Anthony J. Fischer

Pancreatic enzymes digest obstructive meconium from cystic fibrosis pig intestines

doi 10.3389/fped.2024.1387171

1,318 views

Share on

Frontiers in Pediatrics

Frontiers in Pediatrics

Pediatric Gastroenterology, Hepatology and Nutrition

Impact

4,624Topic views
2,913Article views
1,076Article downloads